As extracellular gp96 has been shown to display pro-inflammatory function in autoimmune diseases, we investigated whether inhibition of extracellular gp96 was able to limit immune hyperactivation and hepatic immunopathology in liver failure. This evidence concerns the gene HSP90B1 and liver failure.